Summary
Eye Movement Desensitisation and Reprocessing (EMDR) for symptoms of Post-Traumatic Stress Disorder (PTSD) in adults with intellectual disabilities
Study hypothesis
EMDR provides value for money, improves the mental health and quality of life for people with intellectual difficulties (PwID) who suffer PTSD when compared to standard available treatment
Study Design
The study is designed as a randomised controlled trial (RCT), with internal pilot phases and a nested qualitative study to assess fidelity, adherence and factors that influence primary and secondary outcomes. Patients will be randomised to either a combined Psychoeducation and Stabilisation (PES) and EMDR protocol adapted for PwID or the standard treatment offered locally and followed up for 14 months post-randomisation, with follow-up assessments at 4, 8 and 14 months. Health economic outcomes will be determined from data collected at baseline and 14-month assessments.
Sponsor
Birmingham Community Health Care NHS Foundation Trust
Professor Peter Langdon
Funder: NIHR HTA
Current status
Recruiting – looking for potential sites
Contact Details
Trial Manager / Lead Contact: Stephen Hiles, Swansea Trials Unit
Phone: 01792 602624
Email: trauma-aid@swansea.ac.uk
ISCRTN Number: 35167485; IRAS ID: 260514;